Henry Fechner

4.2k citations

108 papers · 3.1k · h-index 32

Impact in

Cardiology and Cardiovascular Medicine top 2%
- Viral Infections and Immunology Research
Genetics top 1%
- Virus-based gene therapy research

Papers in

Genetics 62
- Virus-based gene therapy research 62
Molecular Biology 57
- RNA Interference and Gene Delivery 36
- Viral Infectious Diseases and Gene Expression in Insects 8

Co-authors: Wolfgang Poller (41 shared papers)Jens Kurreck (41 shared papers)Anja Geisler (16 shared papers)Sandra Pinkert (28 shared papers)Matthias Pauschinger (8 shared papers)Jos M. J. Lamers (6 shared papers)Heinz‐Peter Schultheiß (12 shared papers)Bernd Rüstow (4 shared papers)
Journals: Gene Therapy (9 papers)Journal of Virology (7 papers)Circulation (6 papers)Journal of Molecular Medicine (6 papers)Human Gene Therapy (4 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Henry Fechner

107 papers receiving 3.0k citations

Peers

Countries citing papers authored by Henry Fechner

Since Specialization

Citations

This map shows the geographic impact of Henry Fechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Fechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Fechner more than expected).

Fields of papers citing papers by Henry Fechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Fechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Fechner. The network helps show where Henry Fechner may publish in the future.

Co-authors

The 25 scholars most cited alongside Henry Fechner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry Fechner Line = papers co-authored together Henry Fechner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers Gene Therapy ·Henry Fechner, A Haack, Haopeng Wang, X. Wang, Karin Eizema, Matthias Pauschinger, Regien G. Schoemaker, Richard van Veghel, Adriaan B. Houtsmuller, Schultheiss Hp, Jos M. J. Lamers, Wolfgang Poller	1999	257
2	Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins α _v β ₃ and α _v β ₅ on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy Circulation ·Michel Noutsias, Henry Fechner, Henriëtte de Jonge, Xiaomin Wang, Dick H. W. Dekkers, Adriaan B. Houtsmuller, Matthias Pauschinger, Jeffrey M. Bergelson, Rahat S. Warraich, Magdi H. Yacoub, Roland Hetzer, Jos M. J. Lamers, Heinz‐Peter Schultheiß, Wolfgang Poller	2001	150
3	Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies International Journal of Molecular Sciences ·Thomas Hiller, Johanna Berg, Laura Elomaa, Viola Röhrs, Imran Ullah, Katrin Schaar, Ann-Christin Dietrich, Munir A. Al‐Zeer, Armin Kurtz, Andreas C. Hocke, Stefan Hippenstiel, Henry Fechner, Marie Weinhart, Jens Kurreck	2018	116
4	microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors Gene Therapy ·Anja Geisler, Andreas Jungmann, Jens Kurreck, Wolfgang Poller, Hugo A. Katus, Roland Vetter, Henry Fechner, Oliver J. Müller	2010	105
5	Provirus Variants of the Bovine Leukemia Virus and Their Relation to the Serological Status of Naturally Infected Cattle Virology ·Henry Fechner, P. Blankenstein, A. C. Looman, Jana Elwert, Lutz Geue, Catrin Albrecht, Ants Kurg, Dagmar Beier, Otfried Marquardt, D. Ebner	1997	92
6	HDL is the major source of vitamin E for type II pneumocytes Free Radical Biology and Medicine ·Ingrid Kolleck, Michael Schlame, Henry Fechner, A. C. Looman, Heide Wissel, Bernd Rüstow	1999	85
7	Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells Gene Therapy ·Henry Fechner, X Wang, H Wang, Andreas Jansen, Matthias Pauschinger, Hans Scherübl, Jeffrey M. Bergelson, H-P Schultheiss, Wolfgang Poller	2000	77
8	Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy European Heart Journal ·Carsten Skurk, F. Wittchen, Lennart Suckau, Henning Witt, Michel Noutsias, Henry Fechner, H.-P. Schultheiss, Wolfgang Poller	2008	75
9	Adenovirus-Based Phospholamban Antisense Expression as a Novel Approach to Improve Cardiac Contractile Dysfunction Circulation ·Karin Eizema, Henry Fechner, Karel Bezstarosti, Sonja Schneider-Rasp, Arnoud van der Laarse, Haili Wang, Heinz‐Peter Schultheiß, Wolfgang Poller, Jos M. J. Lamers	2000	72
10	NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis Circulation Heart Failure ·Carsten Tschöpe, Irene Müller, Yu Xia, Konstantinos Savvatis, Kathleen Pappritz, Sandra Pinkert, Dirk Laßner, Markus M. Heimesaat, Frank Spillmann, Kapka Miteva, Stefan Bereswill, Heinz‐Peter Schultheiß, Henry Fechner, Burkert Pieske, Uwe Kühl, Sophie Van Linthout	2017	69
11	Induction of Coxsackievirus-Adenovirus–Receptor Expression During Myocardial Tissue Formation and Remodeling Circulation ·Henry Fechner, Michel Noutsias, Carsten Tschöepe, Kerstin Hinze, Xiaomin Wang, Felicitas Escher, Matthias Pauschinger, Dick H. W. Dekkers, Roland Vetter, Martin Paul, Jos M. J. Lamers, Heinz‐Peter Schultheiß, Wolfgang Poller	2003	69
12	Regulation by vitamin E of the scavenger receptor BI in rat liver and HepG2 cells Journal of Lipid Research ·Wolfgang Witt, Ingrid Kolleck, Henry Fechner, Pranav Sinha, Bernd Rüstow	2000	67
13	Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets Journal of Molecular Medicine ·F. Wittchen, Lennart Suckau, Henning Witt, Carsten Skurk, Dirk Laßner, Henry Fechner, Isaac Sipo, Ute Ungethüm, Patricia Ruíz, Matthias Pauschinger, Carsten Tschöpe, Ursula Rauch, Uwe Kühl, Heinz‐Peter Schultheiß, Wolfgang Poller	2006	66
14	Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy Journal of Molecular Medicine ·Henry Fechner, Isaac Sipo, Dirk Westermann, Sandra Pinkert, Xiaomin Wang, Lennart Suckau, Jens Kurreck, Heinz Zeichhardt, Oliver J. Müller, Roland Vetter, Volker A. Erdmann, Carsten Tschöpe, Wolfgang Poller	2008	65
15	MicroRNA-regulated viral vectors for gene therapy PubMed ·Anja Geisler, Henry Fechner	2016	63
16	Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor Circulation ·Sandra Pinkert, Dirk Westermann, Xiaomin Wang, Karin Klingel, Andrea Dörner, Konstantinos Savvatis, Tobias Größl, Stefanie Krohn, Carsten Tschöpe, Heinz Zeichhardt, Katja Kotsch, Kerstin Weitmann, Wolfgang Hoffmann, Heinz‐Peter Schultheiß, O. Brad Spiller, Wolfgang Poller, Henry Fechner	2009	60
17	Antibody-Mediated Enhancement of Parvovirus B19 Uptake into Endothelial Cells Mediated by a Receptor for Complement Factor C1q Journal of Virology ·Kristina von Kietzell, Tanja Pozzuto, Regine Heilbronn, Tobias Größl, Henry Fechner, Stefan Weger	2014	60
18	α- and δ-tocopherol induce expression of hepatic α-tocopherol-transfer-protein mRNA Biochemical Journal ·Henry Fechner, Michael Schlame, Florian Guthmann, Paul A. Stevens, Bernd Rüstow	1998	58
19	Evaluation of Polymerase Chain Reaction (PCR) Application in Diagnosis of Bovine Leukaemia Virus (BLV) Infection in Naturally Infected Cattle Journal of Veterinary Medicine Series B ·Henry Fechner, Ants Kurg, Lutz Geue, P. Blankenstein, G. Mewes, D. Ebner, Dagmar Beier, G. Mewes, G. Mewes, D. Ebner, D. Ebner	1996	56
20	Colchicine Prevents Disease Progression in Viral Myocarditis Via Modulating the NLRP3 Inflammasome in the Cardiosplenic Axis ESC Heart Failure ·Kathleen Pappritz, Jie Lin, Muhammad El‐Shafeey, Henry Fechner, Uwe Kühl, Alessio Alogna, Frank Spillmann, Ahmed Elsanhoury, Rainer Schulz, Carsten Tschöpe, Sophie Van Linthout	2022	53

About Henry Fechner

Henry Fechner is a scholar working on Genetics, Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology and Immunology, having authored 108 papers that have together received 3.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (62 papers), Viral Infections and Immunology Research (39 papers), RNA Interference and Gene Delivery (36 papers), CAR-T cell therapy research (17 papers), Viral gastroenteritis research and epidemiology (10 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers), T-cell and Retrovirus Studies (7 papers) and Animal Disease Management and Epidemiology (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (943 citations), Genetics (1.1k citations), Immunology (449 citations), Infectious Diseases (378 citations) and Molecular Biology (1.4k citations). Henry Fechner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Wolfgang Poller, Jens Kurreck, Anja Geisler, Sandra Pinkert, Matthias Pauschinger, Jos M. J. Lamers, Heinz‐Peter Schultheiß, Bernd Rüstow, Roland Vetter and Stefan Weger. Their work appears in journals such as Gene Therapy, Journal of Virology, Circulation, Journal of Molecular Medicine and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Henry Fechner

Impact in

Papers in i

In The Last Decade

Henry Fechner

Peers

Countries citing papers authored by Henry Fechner

Fields of papers citing papers by Henry Fechner

All Works

About Henry Fechner

Explore authors with similar magnitude of impact

Papers in